Hypertensive risk factors in kidney disease in African Americans

Kidney International, Supplement

Volumn 63, Issue 83, 2003, Pages

  Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AASK; Global glomerulosclerosis; Hypertension; Hypertensive nephrosclerosis; Race

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTERIOSCLEROSIS; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DNA POLYMORPHISM; FAMILIAL DISEASE; GENE DELETION; GENE INSERTION; GENE MUTATION; HEREDITY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; NEGRO; NEPHROSCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SOCIAL STATUS; UNITED STATES; VASOSPASM; AFRICAN AMERICAN; ETHNOLOGY; RENOVASCULAR HYPERTENSION; REVIEW; STATISTICS;

AFRICAN AMERICANS; HUMANS; HYPERTENSION, RENAL; NEPHROSCLEROSIS; RISK FACTORS;

EID: 0037246021     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s83.5.x     Document Type: Conference Paper

References (50)

1. VALDERRABANO F, GOMEZ-CAMPDERA F, JONES EH: Hypertension as a cause of end-stage renal disease: Lessons from international registries. Kidney Int 54(Suppl 68):S60-66, 1998
2. U.S. RENAL DATA SYSTEM: USRDS 1999 Annual Data Report. Am J Kidney Dis 34(Suppl 1):S40-S151, 1999
3. FREEDMAN BI, SPRAY BJ, TUTTLE AB, BUCKALEW VM: The familial risk of end stage renal disease in African Americans. Am J Kidney Dis 21:387-393, 1993
4. FREEDMAN BI, ISKANDAR SS, APPEL RG: The link between hypertension and nephrosclerosis. Am J Kidney Dis 25:207-221, 1995
5. SCHULMAN NB, FORD CE, HALL WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(Suppl 1):80-93, 1989
6. KLAG MJ, WHELTON PK, RANDALL BL, et al: End stage renal disease in African-American and white men. 16 year MRFIT find-ings. JAMA 277:1293-1298, 1997
7. ROSTAND SG, BROWN G, KIRK KA, et al: Renal insufficiency in treated essential hypertension. N Engl J Med 320:684-688, 1989
8. HEBERT LA, KUSEK JW, GREENE T, et al: Effects of blood pressure control on progressive renal disease in Blacks and Whites. Modification of Diet in Renal Disease Study Group. Hypertension 30:428-435, 1997
9. AGODOA LY, APPEL L, BAKRIS GL, et al: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. African American Study of Kidney Disease and Hypertension (AASK) Study Group. JAMA 285:2719-2728, 2001
10. SUTHANTHIRAN M, KHANNA A, CUKRAN D, et al: Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients. Kidney Int 53:639-644, 1998
11. LI B, KHANNA A, SHARMA V, et al: TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271-275, 1999
12. BLOEM LJ, MANATUNGA AK, TEWKSBURY DA, PRATT JH: The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948-953, 1995
13. DURU K, FARROW S, WANG J-M, et al: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African Americans with hypertension. Am J Hypertens 7:759-762, 1994
14. FOGO A, BREYER JA, SMITH MC, et al: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study on Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 51:244-252, 1997
15. MARCANTONI C, MA L-J, FEDERSPIEL C, FOGO AB: Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 62:172-180, 2002
16. PERNEGER TV, WHELTON PK, KLAG MJ, ROSSITER KD: Diagnosis of hypertensive end stage renal disease: Effect of patients' race. Am J Epidemiol 141:10-15, 1995
17. MCMANUS JFA, LUPTON CH JR: Ischaemic obsolescence of renal glomeruli: The natural history of the lesions and their relation to hypertension. Lab Invest 9:413-434, 1960
18. FAHR T: Pathologische Anatomie des Morbus Brightii, in Hand-buch de Speziellen Pathologische Anatomie und Histologie (vol 6, part 1), edited by HENKE F, LUBARSCH O, Berlin, Springer, 1925, p 156〈/6〉
19. BOHLE A, RATSCHEK M: The compensated and the decompensated form of benign nephrosclerosis. Pathol Pract Res 174:357-367, 1982
20. PICKERING TG: Hypertension in blacks. Curr Opin Nephrol Hyper-tens 3:207-212, 1994
21. WALKER AJ, BASSETT DR, DUEY WJ, et al: Cardiovascular and plasma catecholamine responses to exercise in blacks and whites. Hypertension 20:542-548, 1992
22. TEIBER FA, MUSANTE L, BRADEN D, et al: Racial differences in hemodynamic responses to the cold face stimulus in children and adults. Psychosom Med 53:286-296, 1990
23. LUKE RG: Hypertensive nephrosclerosis: Pathogenesis and prevalence. Nephrol Dial Transplant 14:2271-2278, 1999
24. KINCAID-SMITH P: Clinical diagnosis of hypertensive nephrosclerosis. Nephrol Dial Transplant 14:2255-2267, 1999
25. MEYRIER A, SIMON P, MONTSENY JJ, et al: Vascular nephropathies and nephrosclerosis: Epidemiology and pathophysiology. Adv Nephrol Necker Hosp 26:207-245, 1997
26. KAPPEL B, OLSEN S: Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch 387:271-277, 1980
27. SMITH SM, HOY WE, COBB L: Low incidence of glomerulosclerosis in normal kidneys. Arch Pathol Lab Med 113:1253-1256, 1989
28. TRACY RE, BERENSON GS, CUETO-GARCIA L, et al: Nephrosclerosis and aortic atherosclerosis from age 6 to 70 years in the United States and Mexico. Virchows Arch A Pathol Anat Histopathol 420:479-488, 1992
29. TRACY RE, RIOS-DALENZ JL: Renovasculopathies of hypertension in Hispanic residents of Dallas, Texas. Arch Med Res 30:40-48, 1999
30. TRACY RE, RIOS-DALENZ JL: Rarity of hypertensive stigmata in aging renocortical arteries of Bolivians. Virchows Arch 424:307-314, 1994
31. TAMURA T: Histologic features of renal biopsies from patients with essential hypertension and from the aged. Japanese Circ J 30:829-862, 1966
32. KATAFUCHI R, TAKEBAYASHI S: Morphometrical and functional correlations in benign nephrosclerosis. Clin Nephrol 28:238-243, 1987
33. TRACY RE: Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites. Semin Nephrol 16:126-133, 1996
34. BRENNER BM, CHERTOW GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
35. HACK M, MERKATZ IR: Preterm delivery and low birth weight - A dire legacy. N Eng J Med 333:1772-1773, 1995
36. FOGO AB: Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int 57(Suppl 75):S15-S21, 2000
37. FOGO A, HAWKINS EP, BERRY PL, et al: Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115-123, 1990
38. PESCE C, SCHMIDT K, FOGO A, et al: Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol 7:355-358, 1998
39. SPENCER J, WANG Z, HOY W: Low birth weight and reduced renal volume in Aboriginal children. Am J Kidney Dis 37:915-920, 2001
40. YOUNG RJ, HOY WE, KINCAID-SMITH P, et al: Glomerular size and glomerulosclerosis in Australian Aborigines. Am J Kidney Dis 36:481-489, 2000
41. TEIO KK: Angiotensin converting enzyme genotypes and disease. BMJ 311:76-77, 1995
42. FERGUSON R, GRIM CE, OPGENORTH TJ: A familial risk of chronic renal failure among blacks on dialysis. J Clin Epidemiol 41:1189-1196, 1988
43. HUNLEY TE, JULIAN BA, PHILLIPS JA, et al: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-577, 1996
44. RUTLEDGE DR, KUBILIS P, BROWE CS, ROSS EA: Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients. Biochem Mol Biol Int 35:661-668, 1995
45. DURU K, FARROW S, WANG J-M, et al: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African Americans with hypertension. Am J Hypertens 7:759-762, 1994
46. FERNANDEZ-LLAMA P, POCH E, ORIOLA J, et al: Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 53:1743-1747, 1998
47. FOGO A, YOSHIDA Y, YARED A, ICHIKAWA I: Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38:1068-1074, 1990
48. NIIMURA F, LABOSKY PA, KAKUCHI J, et al: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954, 1995.
49. KREGE JH, KIM HS, MOYER JS, et al: Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29:150-157, 1997
50. MA L-J, NAKAMURA S, WHITSITT JS, et al: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 58:2425-2436, 2000